AbbVie Inc. (ABBV)
NYSE · Healthcare
AbbVie Inc. Shareholder Equity 2011–2025
AbbVie Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- AbbVie Inc. shareholder equity as of December 31, 2025: -3.27B, a 198.35% decrease year-over-year.
- AbbVie Inc. shareholder equity for 2025 were -3.27B, a 198.35% decrease from 2024.
- AbbVie Inc. shareholder equity for 2024 were 3.33B, a 67.91% decrease from 2023.
- AbbVie Inc. shareholder equity for 2023 were 10.36B, a 39.96% decrease from 2022.
- AbbVie Inc. shareholder equity for 2022 were 17.25B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AbbVie Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-3,270 |
| 2024 | $3,325 |
| 2023 | $10,360 |
| 2022 | $17,254 |
| 2021 | $15,408 |
| 2020 | $13,076 |
| 2019 | $-8,172 |
| 2018 | $-8,446 |
| 2017 | $5,097 |
| 2016 | $4,636 |
| 2015 | $3,945 |
| 2014 | $1,742 |
| 2013 | $4,492 |
| 2012 | $-350 |
AbbVie Inc. Shareholder Equity — FAQ
AbbVie Inc. (ABBV) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABBV's shareholder equity history?
The chart and table above show AbbVie Inc.'s shareholder equity by year and by quarter, including the growth rate.